Abstract
Crystal Genetics, Inc. is an early-stage genetic test company, focused on achieving the highest possible clinical-grade accuracy and comprehensiveness for detecting germline (e.g., in hereditary cancer) and somatic (e.g., in early cancer detection) mutations. Crystal's mission is to significantly improve the health status of the population, by providing high accuracy, comprehensive, flexible and affordable genetic tests, primarily in cancer. Crystal's philosophy is that when it comes to detecting mutations that are strongly correlated with life-threatening diseases, the detection accuracy of every single mutation counts: a single false-positive error could cause severe anxiety for the patient. And, more importantly, a single false-negative error could potentially cost the patient's life. Crystal's objective is to eliminate both of these error types.
References
- 1 Precision FDA: A community platform for NGS assay evaluation and regulatory science exploration. precision.fda.gov.
- 2 Illumina. www.illumina.com/platinumgenomes.
- 3 Genome in a Bottle: Authoritative Characterization of Benchmark Human Genomes. www.genomeinabottle.org.
- 4 Crystalgenetics: Data. www.crystalgenetics.com/data.html.